IDH Inhibitors Target Common Glioma Mutation

    Cancer Discovery
    |June 21, 2019
    PubMed

    Insights

    Mutant-selective inhibitors targeting isocitrate dehydrogenase 1 (IDH1) show promise in shrinking brain gliomas. Phase I data indicate a good safety profile, though some experts question the strategy's efficacy.

    Area of Science:

    • Oncology
    • Neuro-oncology
    • Pharmacology

    Background:

    • Phase I clinical trials evaluated three novel mutant-selective isocitrate dehydrogenase 1 (IDH1) inhibitors for glioma treatment.
    • These inhibitors are designed to target specific IDH1 mutations prevalent in certain gliomas.

    Discussion:

    • While initial data suggest these IDH1 inhibitors can reach the brain and reduce glioma tumor size, concerns exist regarding their ultimate clinical utility.
    • Some clinicians express skepticism about the long-term effectiveness and potential for paradoxical tumor progression.

    Key Insights:

    • Mutant-selective IDH1 inhibitors demonstrate target engagement within the brain and show tumor shrinkage in glioma patients.
    • Phase I trials reported an acceptable safety profile for these investigational drugs.

    Outlook:

    • Further clinical trials are necessary to validate the efficacy and long-term outcomes of IDH1 inhibitor therapy.
    • Investigating the mechanisms behind potential treatment futility or accelerated tumor progression is crucial for optimizing therapeutic strategies.

    Related Concept Videos

    Mutations01:39

    Mutations

    Overview
    94.4K
    Mutations01:35

    Mutations

    Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
    Chromosomal Alterations Are Large-Scale Mutations
    While point mutations are changes in a single nucleotide in...
    44.1K
    Eukaryotic Transcription Inhibitors01:52

    Eukaryotic Transcription Inhibitors

    Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
    Eukaryotic transcription inhibitors usually contain two distinct domains, a...
    10.9K
    Viral Mutations00:36

    Viral Mutations

    A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
    39.8K
    Common Ion Effect03:24

    Common Ion Effect

    Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Châtelier’s principle. Consider the dissolution of silver iodide:
    46.1K
    Mutation, Gene Flow, and Genetic Drift01:09

    Mutation, Gene Flow, and Genetic Drift

    In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
    63.3K